EN6

An activator of autophagy

此产品仅用于科学研究，我们不为任何个人用途提供产品和服务

库存: 现货

可选规格

包装

价格

促销价

数量
1mg

￥400.00

320.00

- +
5mg

￥1000.00

800.00

- +
10mg

￥1700.00

1360.00

- +
50mg

￥4575.00

3660.00

- +
100mg

￥5075.00

4060.00

- +

已选 0 种 0 瓶

金额: ￥0.00

首页收藏

Background

EN6 is an activator of autophagy.¹ It inhibits mammalian target of rapamycin complex 1 (mTORC1) signaling by binding covalently to cysteine 277 of the ATP6V1A catalytic subunit of the lysosomal vacuolar ATPase (v-ATPase) and impairing v-ATPase coupling with Rag GTPases. It is selective for inhibition of mTORC1 over mTORC2 signaling. EN6 increases lysosome acidification and increases cellular clearance of TDP-43 protein aggregates, which are a pathological feature of several neurodegenerative diseases, in a v-ATPase-dependent manner in U2OS osteosarcoma cells. It also inhibits mTORC1 signaling and enhances autophagy in mouse skeletal muscle and heart when administered at a dose of 50 mg/kg.

1.Chung, C.Y.-S., Shin, H.R., Berdan, C.A., et al.Covalent targeting of the vacuolar H+-ATPase activates autophagy via mTORC1 inhibitionNat. Chem. Biol.15776-785(2019)